Alex Arfaei
Partner @ Pappas Capital
New York, United States
Alex Arfaei is a startup investor at Pappas Capital in New York. Alex joined Pappas Capital in 2019, bringing with him twelve years of equity research experience and six years of biopharma operating experience. Prior to joining Pappas, he was a Managing Director with BMO Capital Markets where he was a top-ranked senior equity research analyst responsible for pharmaceutical and biotechnology companies. Prior tojoining BMO, Alex was an equity research associate at FBR. He began his career in the pharma industry with operating roles at Endo Pharmaceuticals and Merck, including positions in sales, market research, forecasting and product management.
Last updated:
For AI agents: llms.txt
About Pappas Capital
Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada. They operate three lines of business: Pappas Ventures, their flagship venture arm; Specialized Fund Management, where we create and manage custom-tailoredinvestment vehicles; and Translational Medicine, where we partner with research universities to accelerate the development of their scientific discoveries and inventions.
Pappas Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alex Arfaei
Partner
|
|||
|
Kyle Rasbach
Managing Partner
|
|||
|
Thomas Mathers
Partner
|
|||
|
Ford Worthy
Partner & Senior Advisor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!